Education
About Us
Working with TipRanks
Follow Us
Interpace Diagnostics Group Inc. (IDXG)
:IDXG
IDXG Stock Chart & Stats
$0.94
$0.00(0.00%)
At close: 4:00 PM EST
$0.94
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.44 - $3.17
Previous CloseN/A
Volume34.00
Average Volume (3M)10.96K
Market Cap
$3.81M
Enterprise Value$25.76M
Total Cash (Recent Filing)$1.42M
Total Debt (Recent Filing)$864.00K
Price to Earnings (P/E)3.2
Beta1.29
Next Earnings
May 07, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.03
Shares Outstanding4,428,539
10 Day Avg. Volume14,914
30 Day Avg. Volume10,960
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)-5.34
Price to Sales (P/S)0.25
P/FCF Ratio3.14
Enterprise Value/Market Cap6.76
Enterprise Value/Revenue0.62
Enterprise Value/Gross Profit0.95
Enterprise Value/Ebitda4.25
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Interpace Diagnostics Group News
IDXG FAQ
What was Interpace Diagnostics Group Inc.’s price range in the past 12 months?
Interpace Diagnostics Group Inc. lowest stock price was $0.44 and its highest was $3.17 in the past 12 months.
What is Interpace Diagnostics Group Inc.’s market cap?
Interpace Diagnostics Group Inc.’s market cap is $3.81M.
When is Interpace Diagnostics Group Inc.’s upcoming earnings report date?
Interpace Diagnostics Group Inc.’s upcoming earnings report date is May 07, 2026 which is in 163 days.
How were Interpace Diagnostics Group Inc.’s earnings last quarter?
Interpace Diagnostics Group Inc. released its earnings results on Nov 12, 2025. The company reported $0.033 earnings per share for the quarter, beating the consensus estimate of N/A by $0.033.
Is Interpace Diagnostics Group Inc. overvalued?
According to Wall Street analysts Interpace Diagnostics Group Inc.’s price is currently Overvalued.
Does Interpace Diagnostics Group Inc. pay dividends?
Interpace Diagnostics Group Inc. does not currently pay dividends.
What is Interpace Diagnostics Group Inc.’s EPS estimate?
Interpace Diagnostics Group Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Interpace Diagnostics Group Inc. have?
Interpace Diagnostics Group Inc. has 4,428,539 shares outstanding.
What happened to Interpace Diagnostics Group Inc.’s price movement after its last earnings report?
Interpace Diagnostics Group Inc. reported an EPS of $0.033 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -3%.
Which hedge fund is a major shareholder of Interpace Diagnostics Group Inc.?
Currently, no hedge funds are holding shares in IDXG
Company Description
Interpace Diagnostics Group Inc.
Interpace Diagnostics Group (IDXG) is a biotechnology company specializing in developing and commercializing molecular diagnostic tests for cancer and other diseases. The company operates primarily in the healthcare sector, focusing on providing innovative diagnostic solutions that aid in the early detection and management of cancer, particularly in the gastrointestinal field. IDXG's core products include a portfolio of molecular tests designed to improve diagnostic accuracy and inform treatment decisions for patients, thereby enhancing patient outcomes.
Technical Analysis
Check-Cap
―
ENDRA Life Sciences
―
Intelligent Bio Solutions
―
Mainz Biomed B.V.
―
bioAffinity Technologies, Inc.
―
Ownership Overview
Options Prices
Currently, No data available
---